| Literature DB >> 29286018 |
Giorgio Calleris1, Giancarlo Marra1, Silvia Corcione2, Marco Oderda1, Chiara Cardellino2, Sabrina Audagnotto2, Bruno Frea1, Francesco Giuseppe De Rosa2, Paolo Gontero1.
Abstract
Intravesical Bacillus Calmette-Guérin (BCG) immunotherapy decreases the progression risk of non-muscle-invasive bladder cancer, but potentially yields a broad spectrum of side effects. We report the case of a 73-year-old man affected by miliary pulmonary BCG infection, whose microbiological diagnosis was probably hindered by empiric fluoroquinolones, focusing on imaging and clinical work-up.Entities:
Mesh：
Substances：
Year: 2017 PMID： 29286018
Source DB: PubMed Journal: Infez Med ISSN： 1124-9390